Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Chen, Jianjun ^a,b   Zhang, Fenghua ^a   Fang, Fang ^a   Chang, Haiyan ^a   Chen, Ze ^a,b,c  

^a HUNAN NORMAL UNIVERSITY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; MATERNAL ANTIBODY; SIALIDASE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY; VIRUS ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; DRUG COMPETITION; DRUG INHIBITION; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PROGENY; SURVIVAL RATE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; LUNG; MORTALITY; NEWBORN; ORTHOMYXOVIRUS INFECTION; PASSIVE IMMUNIZATION; PLASMID; PREGNANCY; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, MATERNALLY-ACQUIRED; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; KAPLAN-MEIERS ESTIMATE; LUNG; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; PREGNANCY; VACCINES, DNA; VACCINES, INACTIVATED;

EID: 38049183161     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-118     Document Type: Article

References (41)

1. Murphy BR Webster RG Orthomyxoviruses Philadelphia/New York: Lippincott Raven 1996
2. Hoberman A Greenberg DP Paradise JL Rockette HE Lave JR Kearney DH Colborn DK Kurs-Lasky M Haralam MA Byers CJ Zoffel LM Fabian IA Bernard BS Kerr JD Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: A randomized controlled trial Jama 2003, 290(12):1608-1616. 10.1001/jama.290.12.1608 14506120
3. Maeda T Shintani Y Nakano K Terashima K Yamada Y Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months Pediatr Int 2004, 46(2):122-125. 10.1046/j.1442-200x.2004.01852.x 15056235
4. Eickhoff TC Sherman IL Serfling RE Observations on excess mortality associated with epidemic influenza Jama 1961, 176:776-782. 13726091
5. Wilson WD Mihalyi JE Hussey S Lunn DP Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination Equine Vet J 2001, 33(7):644-650. 10.2746/042516401776249435 11770984
6. Radu DL Antohi S Bot A Miller A Mirarchi A Bona C Effect of maternal antibodies on influenza virus-specific immune response elicited by inactivated virus and naked DNA Scand J Immunol 2001, 53(5):475-482. 10.1046/j.1365-3083.2001.00896.x 11309155
7. van Maanen C Bruin G de Boer-Luijtze E Smolders G de Boer GF Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza Vet Q 1992, 14(1):13-17. 1574831
8. Englund J Glezen WP Piedra PA Maternal immunization against viral disease Vaccine 1998, 16(14-15):1456-1463. 10.1016/S0264-410X(98)00108-X 9711788
9. Insel RA Amstey M Woodin K Pichichero M Maternal immunization to prevent infectious diseases in the neonate or infant Int J Technol Assess Health Care 1994, 10(1):143-153. 8157447
10. Reuman PD Kris RM Ayoub EM Small PA Jr Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition Microbios 1988, 54(220-221):135-147. 2846987
11. Reuman PD Paganini CM Ayoub EM Small PA Jr Maternal-infant transfer of influenza-specific immunity in the mouse J Immunol 1983, 130(2):932-936. 6848601
12. Englund JA Mbawuike IN Hammill H Holleman MC Baxter BD Glezen WP Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants J Infect Dis 1993, 168(3):647-656. 8354906
13. Reuman PD Ayoub EM Small PA Effect of passive maternal antibody on influenza illness in children: A prospective study of influenza A in mother-infant pairs Pediatr Infect Dis J 1987, 6(4):398-403. 3588113
14. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention MMWR Recomm Rep 1998 47 RR-6 1 26
15. Zhang F Chen J Fang F Zhou Y Wu J Chang H Zhang R Wang F Li X Wang H Ma G Chen Z Maternal Immunization with Both Hemagglutinin- and Neuraminidase-Expressing DNAs Provides an Enhanced Protection Against a Lethal Influenza Virus Challenge in Infant and Adult Mice DNA Cell Biol 2005, 24(11):758-765. 10.1089/dna.2005.24.758 16274296
16. Stewien KE Barbosa V de Lima OS Osiro K The influence of maternally derived antibody on the efficacy of further attenuated measles vaccine Infection 1978, 6(5):207-210. 10.1007/BF01642310 730390
17. Albrecht P Ennis FA Saltzman EJ Krugman S Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure J Pediatr 1977, 91(5):715-718. 10.1016/S0022-3476(77)81021-4 909009
18. Letson GW Shapiro CN Kuehn D Gardea C Welty TK Krause DS Lambert SB Margolis HS Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants J Pediatr 2004, 144(3):327-332. 10.1016/ j.jpeds.2003.11.030 15001936
19. Murphy BR Olmsted RA Collins PL Chanock RM Prince GA Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses J Virol 1988, 62(10):3907-3910. 253544 3047432
20. Zanetta RA Amaku M Azevedo RS Zanetta DM Burattini MN Massad E Optimal age for vaccination against measles in the State of Sao Paulo, Brazil, taking into account the mother's serostatus Vaccine 2001, 20(1-2):226-234. 10.1016/S0264-410X(01)00267-5 11567768
21. Lagos R Munoz A Dumas R Pichon S Zambrano B Levine M Vidor E Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies Vaccine 2003, 21(25-26):3730-3733. 10.1016/S0264-410X(03)00385-2 12922104
22. Harte PG Rogers N Targett GA Playfair JH Maternal inhibition of malaria vaccination in mice can be overcome by giving a second dose of vaccine Immunology 1984, 53(3):401-409. 1454913 6237985
23. Knudsen KM Aaby P Whittle H Rowe M Samb B Simondon F Sterne J Fine P Child mortality following standard, medium or high titre measles immunization in West Africa Int J Epidemiol 1996, 25(3):665-673. 10.1093/ ije/25.3.665 8671571
24. Capozzo AV Cuberos L Levine MM Pasetti MF Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers Infect Immun 2004, 72(8):4637-4646. 470595 15271924 10.1128/IAI.72.8.4637-4646.2004
25. Schlereth B Rose JK Buonocore L ter Meulen V Niewiesk S Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies J Virol 2000, 74(10):4652-4657. 111985 10775601 10.1128/JVI.74.10.4652-4657.2000
26. Manickan E Yu Z Rouse BT DNA immunization of neonates induces immunity despite the presence of maternal antibody J Clin Invest 1997, 100(9):2371-2375. 508435 9410917
27. Premenko-Lanier M Rota PA Rhodes G Verhoeven D Barouch DH Lerche NW Letvin NL Bellini WJ McChesney MB DNA vaccination of infants in the presence of maternal antibody: A measles model in the primate Virology 2003, 307(1):67-75. 10.1016/S0042-6822(02)00036-3 12667815
28. Wang Y Xiang Z Pasquini S Ertl HC Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus J Virol 1998, 72(3):1790-1796. 109468 9499029
29. Pertmer TM Oran AE Moser JM Madorin CA Robinson HL DNA vaccines for influenza virus: Differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein J Virol 2000, 74(17):7787-7793. 112308 10933685 10.1128/JVI.74.17.7787-7793.2000
30. Siegrist CA Mechanisms by which maternal antibodies influence infant vaccine responses: Review of hypotheses and definition of main determinants Vaccine 2003, 21:3406-3412. 10.1016/S0264-410X(03)00342-6 12850349
31. Aymard M Ferraris O Gerentes L Jolly J Kessler N Neuraminidase assays Dev Biol (Basel) 2003, 115:75-83. 15088778
32. Chen Z Sahashi Y Matsuo K Asanuma H Takahashi H Iwasaki T Suzuki Y Aizawa C Kurata T Tamura S Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza Vaccine 1998, 16(16):1544-1549. 10.1016/S0264-410X(98)00043-7 9711802
33. Niwa H Yamamura K Miyazaki J Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 1991, 108(2):193-199. 10.1016/0378-1119(91)90434-D 1660837
34. Aihara H Miyazaki J Gene transfer into muscle by electroporation in vivo Nat Biotechnol 1998, 16(9):867-870. 10.1038/nbt0998-867 9743122
35. Tamura SI Asanuma H Ito Y Hirabayashi Y Suzuki Y Nagamine T Aizawa C Kurata T Oya A Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine Eur J Immunol 1992, 22(2):477-481. 10.1002/eji.1830220228 1537382
36. Li X Fang F Song Y Yan H Chang H Sun S Chen Z Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection DNA Cell Biol 2006, 25(4):197-205. 10.1089/dna.2006.25.197 16629592
37. Phelan MA Mayner RE Bucher DJ Ennis FA Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents J Biol Stand 1980, 8(3):233-242. 10.1016/ S0092-1157(80)80039-4 7410447
38. Chen Z Kadowaki S Hagiwara Y Yoshikawa T Matsuo K Kurata T Tamura S Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase Vaccine 2000, 18(28):3214-3222. 10.1016/ S0264-410X(00)00149-3 10869766
39. Chen Z Yoshikawa T Kadowaki S Hagiwara Y Matsuo K Asanuma H Aizawa C Kurata T Tamura S Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein J Gen Virol 1999, 80(Pt 10):2559-2564. 10573147
40. Chen J Fang F Li X Chang H Chen Z Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation Vaccine 2005, 23(34):4322-4328. 10.1016/j.vaccine.2005.03.035 15925433
41. Reed LJ Muench H A simple method of estimating fifty per cent endpoints Am J Hyg 1938, 27:493-497.